DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF OLANZAPINE IN MARKETED FORMULATION
Abstract
A simple, accurate, precise and rapid stability indicating RP-HPLC method was developed and validated for the analysis of Olanzapine in marketed formulation. Analysis was performed on a C-18 (250mm x 4.60mm, 5 µm) column as stationary phase and using mobile phase which was Potassium di-hydrogen phosphate Buffer (pH 6): Acetonitrile (60:40) (v/v) at a flow rate of 1ml/min with UV detection at 258 nm at constant room temperature. The injection volume was 20 µl and the chromatographic runtime of 5 min was used. Proposed method was found to be linear in the range of 5-25 μg/ml with the correlation coefficient 0.998. The validation and the reliability of proposed method were assessed by recovery study. The recovery of added standards (80%, 100% 120%) was ranging from 99.58% - 100.50%. The robustness of developed method was checked by changing temperature, flow rate and mobile phase ratio.
DOI
https://doi.org/10.22270/jddt.v7i7.1607References
Zhang M, Jia J, Chuan LU, Development and Validation of a liquid chromatography-isotope dilution tandem mass spectrometry for determination of olanzapine in human plasma and its application to bioavailability study, Acta Pharm Sin, 2010, 45, 6, 767-771.
Mahmoud AT, Nagiba YH, Nariman AE, Mohamed A, Simultaneous determination of Olanzapine and Fluoxetine hydrochloride in capsules by spectrophotometry, TLC-spectrodensitometry and HPLC, JAR, 2013, 4, 173–180.
Raja A, Venkateshwar R J, Development and Validation Of new RP-UPLC method for the Quantitative Determination of Olanzapine in Tablet Dosage form , Asian J Pharm Clin Res, 2013, 6, 3, 178- 181.
Published
Abstract Display: 989 
PDF Downloads: 735 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.